Concepedia

Sally C. Marshall

SC

Statistics

Publications

3

Citations

243

H-Index

3

Active since

1995

Affiliations

Pfizer (United States)(Current)

Sally C. Marshall is an author at Pfizer (United States) specializing in chemical biology, drug development, and drug discovery.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryChemical BiologyDrug DevelopmentNatural SciencesMolecular DockingMedicinal ChemistryMolecular Pharmacology

Publications per year

1995–1995

3

Publications

3

Transcriptional Repression by Msx-1 Does Not Require Homeodomain DNA-Binding Sites

K M Catron, Hailan Zhang, Sally C. Marshall et al. · Molecular and Cellular Biology · 1995 · 169 citations · Full text

Synthesis and in vitro profile of a novel series of catechol benzimidazoles. The discovery of potent, selective phosphodiesterase type IV inhibitors with greatly attenuated affinity for the [3H]rolipram binding site

John B. Cheng, Kelvin Cooper, Allen J. Duplantier et al. · Bioorganic & Medicinal Chemistry Letters · 1995 · 45 citations

Catechol Benzimidazoles, Medicinal Chemistry, Novel Series +11

Discovery of micromolar PDE IV inhibitors that exhibit much reduced affinity for the [3H]rolipram binding site: 3-norbornyloxy-4-methoxyphenylmethylene oxindoles

Hiroko Masamune, John B. Cheng, Kelvin Cooper et al. · Bioorganic & Medicinal Chemistry Letters · 1995 · 29 citations

Molecular Pharmacology, 3-Norbornyloxy-4-methoxyphenylmethylene Oxindoles, Drug Target +9

1–3 of 3